Michael D Lyon

age ~66

from Beverly Hills, FL

Get Report

Also known as:

Michael Dean Lyon
Mike D Lyon
Maichael D Lyon
Michael D Gallagher
Dean Lyon

Connected to:

Michael Lyon Phones & Addresses

Beverly Hills, FL
Delray Beach, FL
Federal Heights, CO
Thornton, CO
Fort Mill, SC
Arvada, CO
Englewood, CO
Fort Worth, TX
Brandon, FL
5202 Helena St, Denver, CO 80239

Work

Position:

Private Household Service Occupations

Education

Degree:

Graduate or professional degree

Lawyers & Attorneys

Michael J Lyon - Lawyer

view source

Licenses:

Dist. of Columbia - Active 1985

Michael Lyon - Lawyer

view source

Office:

Lindhorst & Dreidame Co., L.P.A.

Specialties:

Medical Malpractice
Wrongful Death

ISLN:

905295679

Admitted:

1975

University:

Xavier University, B.A., 1969

Law School:

Salmon P. Chase College of Law, J.D., 1975

Michael Lyon - Lawyer

view source

ISLN:

913611157

Admitted:

1982

Isbn (Books And Publications)

Migration and Race Relations in an English City: A Study in Bristol

view source

Author
Michael Lyon

ISBN #
0192184067

Name / Title

Company / Classification

Phones & Addresses

Michael Lyon
Secretary/treasurer

Pro-tech Network Solutions Inc
Computers - Dealers

Po Box 1330 622 Connaught Dr 2flr, Jasper, AB T0E 1E0
7808523999, 7808523999

Michael Lyon
Secretary/treasurer

Pro-tech Network Solutions Inc
Computers - Dealers

7808523999, 7808523999

Michael R. Lyon

Sci Bellagio at Bent Tree Fund 22, LLC

Michael C. Lyon

MGM ROOFING, LLC

Michael C. Lyon

MGM, INC

Michael C. Lyon

GREEN EXTERIOR CONCEPTS, LLC

Michael Lyon
President,Treasurer,Chairman

THE WESS COMPANY INTERNATIONAL

Michael Lyon
Director, President

Michael R. Lyon Holdings Inc

Us Patents

Pyrrolopyridines As Kinase Inhibitors
view source
US Patent:

8178131, May 15, 2012
Filed:

May 13, 2009
Appl. No.:

12/992468
Inventors:

Yvan Le Huerou - Boulder CO, US
James F. Blake - Boulder CO, US
Indrani W. Gunawardana - Boulder CO, US
Peter J. Mohr - Boulder CO, US
Eli M. Wallace - Boulder CO, US
Bin Wang - Boulder CO, US
Mark Joseph Chicarelli - Boulder CO, US
Michael Lyon - Boulder CO, US
Assignee:

Array BioPharma Inc. - Boulder CO
International Classification:

A61K 33/24
A61K 31/437
A61K 31/7068
A61K 31/4745
A61K 31/513
A61K 31/497
A61K 31/506
A61K 31/501
A61K 31/498
A61K 31/5377
A61K 31/55
A61P 35/00
C07D 471/04
US Classification:

424649, 51421018, 51421021, 51421707, 5142328, 514249, 51425201, 51425505, 514256, 514274, 514283, 514300, 514 49, 540597, 544127, 544238, 544333, 544355, 544405, 546113
Abstract:

Compounds of Formula (I) are useful for inhibition of CHK1 and/or CHK2. Methods of using compounds of Formula (I) and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.

Pyrrolopyridines As Kinase Inhibitors
view source
US Patent:

8545897, Oct 1, 2013
Filed:

Mar 20, 2012
Appl. No.:

13/425186
Inventors:

Yvan Le Huerou - Boulder CO, US
James F. Blake - Boulder CO, US
Indrani W. Gunwardana - Boulder CO, US
Pete Mohr - Boulder CO, US
Eli M. Wallace - Boulder CO, US
Bin Wang - Boulder CO, US
Mark Joseph Chicarelli - Boulder CO, US
Michael Lyon - Boulder CO, US
Assignee:

Array BioPharma Inc. - Boulder CO
International Classification:

A61K 31/4545
A61K 31/437
A61K 31/497
A61K 31/506
A61K 33/24
A61K 31/513
A61K 31/444
A61K 31/501
A61P 35/00
US Classification:

424649, 51421018, 51421021, 514249, 51425204, 51425505, 514256, 514274, 514278, 514283, 514300, 514 49
Abstract:

Compounds of Formula I are useful for inhibition of CHK1 and/or CHK2. Methods of using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.

Serine/Threonine Kinase Inhibitors
view source
US Patent:

20170348310, Dec 7, 2017
Filed:

Aug 23, 2017
Appl. No.:

15/684733
Inventors:

- Boulder CO, US
- South San Francisco CA, US
Indrani W. Gunawardana - Boulder CO, US
Kevin W. Hunt - Boulder CO, US
Michael Lyon - Boulder CO, US
Andrew T. Metcalf - Boulder CO, US
Peter J. Mohr - Boulder CO, US
David A. Moreno - Boulder CO, US
Brad Newhouse - Boulder CO, US
Li Ren - Boulder CO, US
Tony P. Tang - Boulder CO, US
Allen A. Thomas - Boulder CO, US
Jacob Schwarz - South San Francisco CA, US
Jane Schmidt - South San Francisco CA, US
Lewis Gazzard - South San Francisco CA, US
Huifen Chen - South San Francisco CA, US
Assignee:

Array BioPharma Inc. - Boulder CO
Genentech, Inc. - South San Francisco CA
International Classification:

A61K 31/506
C07D 417/14
C07D 405/14
C07D 403/04
A61K 31/4439
C07D 401/14
A61K 45/06
A61K 31/444
C07D 471/04
C07D 403/14
Abstract:

Compounds of Formula I or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof are provided, which are useful for the treatment of hyperproliferative, pain and inflammatory diseases. Methods of using compounds of Formula I or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.

Pyrrolopyridines As Kinase Inhibitors
view source
US Patent:

20160368916, Dec 22, 2016
Filed:

Jan 5, 2016
Appl. No.:

14/988521
Inventors:

- Boulder CO, US
James F. Blake - Boulder CO, US
Indrani W. Gunawardana - Boulder CO, US
Peter J. Mohr - Boulder CO, US
Eli M. Wallace - Boulder CO, US
Bin Wang - Boulder CO, US
Mark Joseph Chicarelli - Boulder CO, US
Michael Lyon - Boulder CO, US
Assignee:

Array BioPharma Inc. - Boulder CO
International Classification:

C07D 471/04
C07D 519/00
Abstract:

Compounds of Formula I are useful for inhibition of CHK1 and/or CHK2. Methods of using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.

Serine/Threonine Kinase Inhibitors
view source
US Patent:

20160303126, Oct 20, 2016
Filed:

Jun 29, 2016
Appl. No.:

15/197479
Inventors:

- Boulder CO, US
- South San Francisco CA, US
Indrani W. Gunawardana - Boulder CO, US
Kevin W. Hunt - Boulder CO, US
Michael Lyon - Boulder CO, US
Andrew T. Metcalf - Boulder CO, US
Peter J. Mohr - Boulder CO, US
David A. Moreno - Boulder CO, US
Brad Newhouse - Boulder CO, US
Li Ren - Boulder CO, US
Tony P. Tang - Boulder CO, US
Allen A. Thomas - Boulder CO, US
Jacob Schwarz - South San Francisco CA, US
Jane Schmidt - South San Francisco CA, US
Lewis Gazzard - South San Francisco CA, US
Huifen Chen - South San Francisco CA, US
Assignee:

Array BioPharma Inc. - Boulder
Genentech, Inc. - South San Francisco CA
International Classification:

A61K 31/506
C07D 403/14
C07D 471/04
A61K 31/4439
C07D 417/14
C07D 403/04
C07D 401/14
A61K 31/444
A61K 45/06
C07D 405/14
Abstract:

Compounds of Formula I or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof are provided, which are useful for the treatment of hyperproliferative, pain and inflammatory diseases. Methods of using compounds of Formula I or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.

Serine/Threonine Kinase Inhibitors
view source
US Patent:

20160304519, Oct 20, 2016
Filed:

Jun 29, 2016
Appl. No.:

15/197445
Inventors:

- Boulder CO, US
- South San Francisco CA, US
John Gaudino - Boulder CO, US
Indrani W. Gunawardana - Boulder CO, US
Erik James Hicken - Boulder CO, US
Kevin W. Hunt - Boulder CO, US
Michael Lyon - Boulder CO, US
Andrew T. Metcalf - Boulder CO, US
Peter J. Mohr - Boulder CO, US
David A. Moreno - Boulder CO, US
Brad Newhouse - Boulder CO, US
Li Ren - Boulder CO, US
Jacob Schwarz - South San Francisco CA, US
Huifen Chen - South San Francisco CA, US
Lewis Gazzard - South San Francisco CA, US
Jane Schmidt - South San Francisco CA, US
Steve Do - South San Francisco CA, US
Assignee:

Array BioPharma Inc. - Boulder CO
Genentech, Inc. - South San Francisco CA
International Classification:

C07D 471/04
A61K 31/5377
A61K 31/55
A61K 31/444
C07D 487/04
C07D 519/00
A61K 45/06
A61K 31/506
Abstract:

Compounds of Formula I or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof are provided, which are useful for the treatment of diseases. Methods of using compounds of Formula I or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such diseases, or associated pathological conditions are disclosed.

Pyrrolopyridines As Kinase Inhibitors
view source
US Patent:

20150322061, Nov 12, 2015
Filed:

Jan 7, 2015
Appl. No.:

14/591691
Inventors:

- Boulder CO, US
James F. Blake - Boulder CO, US
Indrani W. Gunawardana - Boulder CO, US
Peter J. Mohr - Boulder CO, US
Eli M. Wallace - Boulder CO, US
Bin Wang - Boulder CO, US
Mark Joseph Chicarelli - Boulder CO, US
Michael Lyon - Boulder CO, US
Assignee:

ARRAY BIOPHARMA INC. - Boulder CO
International Classification:

C07D 471/04
Abstract:

Compounds of Formula I are useful for inhibition of CHK1 and/or CHK2. Methods of using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.

Pyrrolopyridines As Kinase Inhibitors
view source
US Patent:

20140243520, Aug 28, 2014
Filed:

May 6, 2014
Appl. No.:

14/271129
Inventors:

- Boulder CO, US
James F. Blake - Boulder CO, US
Indrani W. Gunawardana - Boulder CO, US
Peter J. Mohr - Boulder CO, US
Eli M. Wallace - Boulder CO, US
Bin Wang - Boulder CO, US
Mark Joseph Chicarelli - Boulder CO, US
Michael Lyon - Boulder CO, US
Assignee:

Array BioPharma Inc. - Boulder CO
International Classification:

C07D 471/04
US Classification:

540597, 546113, 546 15, 544333, 544238, 544405, 544355, 544127
Abstract:

Compounds of Formula I are useful for inhibition of CHK1 and/or CHK2. Methods of using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.

License Records

Michael L Lyon

License #:

2705056181 - Expired

Category:

Contractor

Issued Date:

Apr 21, 2000

Expiration Date:

Apr 30, 2004

Type:

Class C

Michael Gerard Lyon Md

License #:

15538 - Expired

Category:

Medicine

Issued Date:

Oct 29, 1980

Effective Date:

Oct 1, 1988

Type:

Physician

Michael Howard Lyon

License #:

30045 - Expired

Category:

Nursing

Issued Date:

Aug 11, 1975

Effective Date:

Nov 1, 2004

Expiration Date:

Oct 31, 2004

Type:

Registered Nurse

Resumes

Michael Lyon

view source

Michael Lyon

view source

Michael Lyon

view source

Michael Lyon

view source

Michael Lyon

view source

Michael Lyon

view source

Michael Lyon

view source

Location:

United States

Michael Lyon York, SC

view source

Skills:

Some carpenter work and forklift driver work at 84 lumber saw wood and stack wood.

Medicine Doctors

Michael G. Lyon

view source

Specialties:

Immunology, Rheumatology

Work:

VA Palo Alto Health Care Rheumatology
4951 Arroyo Rd BLDG 62 FL 3, Livermore, CA 94550
6504935000 (phone), 9254496522 (fax)

Stanford Hospitals Medical Specialties
300 Pasteur Dr RM S025, Stanford, CA 94305
6507236961 (phone), 6507258418 (fax)

Education:

Medical School
Creighton University School of Medicine
Graduated: 1979

Procedures:

Arthrocentesis

Conditions:

Gout
Rheumatoid Arthritis
Anemia
Ankylosing Spondylitis (AS)
Atrial Fibrillation and Atrial Flutter

Languages:

English

Description:

Dr. Lyon graduated from the Creighton University School of Medicine in 1979. He works in Stanford, CA and 1 other location and specializes in Immunology and Rheumatology. Dr. Lyon is affiliated with Stanford Hospital.